Meeting
2014 ASCO Annual Meeting
Laparoscopic versus laparotomic cytoreduction in patients with advanced ovarian cancer submitted to NACT: Evaluation of oncologic safety.
Authors
Giovanni Favero
Department of Gynecology - Instituto do Câncer do Estado de São Paulo - ICESP Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Giovanni Favero , Nathalia Macerox , Tatiana Pfiffer , Altamiro Ribeiro , Vanessa Costa Miranda , Maria Del Pillar Estevez Diz , Edmund Chada Baracat , Jesus Paula Carvalho
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 5589)
DOI
10.1200/jco.2014.32.15_suppl.5589
Abstract #
5589
Poster Bd #
371
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Validation of the integrated prediction model algorithm for outcome of cytoreduction in advanced ovarian cancer.
First Author: Sabrina Piedimonte
Poster
2013 ASCO Annual Meeting
Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients not candidates for optimal primary surgery: Safety and effectivenes.
First Author: Vanessa Costa Miranda
First Author: Elena Ioana Braicu
Poster
2023 ASCO Annual Meeting
Anlotinib combined with carboplatin/paclitaxel and maintenance anlotinib as front-line treatment for newly diagnosed advanced ovarian cancer: A phase II, single-arm, multicenter study (ALTER-GO-010).
First Author: Yi Jiang